reiterateTJXfinnhub
Wells Fargo Reiterates Equal-Weight Rating on The TJX Companies, Inc. (TJX)
Wells Fargo reiterated its Equal-Weight rating on The TJX Companies, Inc. (NYSE:TJX) on August 20, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Wells Fargo reiterated its Equal-Weight rating on The TJX Companies, Inc. (NYSE:TJX) on August 20, 2026.
Read moreNeedham reiterated its Buy rating on Analog Devices, Inc. (NASDAQ:ADI) on August 20, 2026.
Read moreSeaport Global analysts upgraded Analog Devices, Inc. (NASDAQ:ADI) from Neutral to Buy on August 20, 2026.
Read moreTD Cowen reiterated its Buy rating on Analog Devices, Inc. (NASDAQ:ADI) on August 20, 2026.
Read moreJP Morgan reiterated its Overweight rating on Analog Devices, Inc. (NASDAQ:ADI) on August 20, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Analog Devices, Inc. (NASDAQ:ADI) on August 20, 2026.
Read moreBernstein analysts upgraded Analog Devices, Inc. (NASDAQ:ADI) from Market Perform to Outperform on August 20, 2026.
Read moreWells Fargo reiterated its Overweight rating on Analog Devices, Inc. (NASDAQ:ADI) on August 20, 2026.
Read morePiper Sandler reiterated its Overweight rating on Amgen Inc. (NASDAQ:AMGN) on August 20, 2026.
Read moreRosenblatt analysts initiated coverage on Shopify Inc. (NASDAQ:SHOP) with a rating of Buy on August 20, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Salesforce, Inc. (NYSE:CRM) on August 20, 2026.
Read moreGuggenheim reiterated its Buy rating on Salesforce, Inc. (NYSE:CRM) on August 20, 2026.
Read moreBMO Capital reiterated its Outperform rating on Salesforce, Inc. (NYSE:CRM) on August 20, 2026.
Read moreMorgan Stanley analysts upgraded Merck & Co., Inc. (NYSE:MRK) from Equal-Weight to Overweight on August 20, 2026.
Read moreRBC Capital analysts downgraded Merck & Co., Inc. (NYSE:MRK) from Outperform to Sector Perform on August 20, 2026.
Read moreBMO Capital reiterated its Outperform rating on Merck & Co., Inc. (NYSE:MRK) on August 20, 2026.
Read moreUBS reiterated its Buy rating on Merck & Co., Inc. (NYSE:MRK) on August 20, 2026.
Read morePiper Sandler reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) on August 20, 2026.
Read moreRBC Capital reiterated its Outperform rating on NVIDIA Corporation (NASDAQ:NVDA) on August 20, 2026.
Read moreAscendiant Capital reiterated its Buy rating on AIM ImmunoTech Inc. (AMEX:AIM) on August 20, 2026.
Read more